Celldex Therapeutics Inc (CLDX)
37.77
-1.08
(-2.78%)
USD |
NASDAQ |
Apr 23, 16:00
37.77
0.00 (0.00%)
After-Hours: 17:40
Celldex Therapeutics Cash and Short Term Investments (Quarterly): 423.60M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 423.60M |
| September 30, 2023 | 235.35M |
| June 30, 2023 | 252.70M |
| March 31, 2023 | 278.39M |
| December 31, 2022 | 304.95M |
| September 30, 2022 | 323.47M |
| June 30, 2022 | 356.82M |
| March 31, 2022 | 380.47M |
| December 31, 2021 | 408.25M |
| September 30, 2021 | 423.09M |
| June 30, 2021 | 164.04M |
| March 31, 2021 | 176.08M |
| December 31, 2020 | 194.42M |
| September 30, 2020 | 199.59M |
| June 30, 2020 | 206.92M |
| March 31, 2020 | 53.72M |
| December 31, 2019 | 64.38M |
| September 30, 2019 | 72.92M |
| June 30, 2019 | 81.34M |
| March 31, 2019 | 85.07M |
| December 31, 2018 | 94.02M |
| September 30, 2018 | 105.62M |
| June 30, 2018 | 114.01M |
| March 31, 2018 | 123.25M |
| December 31, 2017 | 139.43M |
| Date | Value |
|---|---|
| September 30, 2017 | 140.53M |
| June 30, 2017 | 153.98M |
| March 31, 2017 | 167.02M |
| December 31, 2016 | 189.78M |
| September 30, 2016 | 203.25M |
| June 30, 2016 | 220.13M |
| March 31, 2016 | 254.02M |
| December 31, 2015 | 289.89M |
| September 30, 2015 | 304.61M |
| June 30, 2015 | 333.99M |
| March 31, 2015 | 359.77M |
| December 31, 2014 | 201.04M |
| September 30, 2014 | 224.08M |
| June 30, 2014 | 252.37M |
| March 31, 2014 | 274.23M |
| December 31, 2013 | 302.98M |
| September 30, 2013 | 136.59M |
| June 30, 2013 | 154.98M |
| March 31, 2013 | 182.38M |
| December 31, 2012 | 83.96M |
| September 30, 2012 | 77.62M |
| June 30, 2012 | 78.67M |
| March 31, 2012 | 92.13M |
| December 31, 2011 | 53.31M |
| September 30, 2011 | 62.77M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
53.72M
Minimum
Mar 2020
423.60M
Maximum
Dec 2023
242.13M
Average
235.35M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | 2.00M |
| Perspective Therapeutics Inc | 9.238M |
| Electromed Inc | 10.43M |
| Xtant Medical Holdings Inc | 5.715M |
| Asensus Surgical Inc | 21.07M |